TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
0.336
+0.008 (2.50%)
At close: Nov 20, 2024, 4:00 PM
0.329
-0.008 (-2.23%)
After-hours: Nov 20, 2024, 4:30 PM EST
TransCode Therapeutics Employees
TransCode Therapeutics had 10 employees as of December 31, 2023. The number of employees decreased by 9 or -47.37% compared to the previous year.
Employees
10
Change (1Y)
-9
Growth (1Y)
-47.37%
Revenue / Employee
n/a
Profits / Employee
-$1,492,656
Market Cap
5.80M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 10 | -9 | -47.37% |
| Dec 31, 2022 | 19 | 10 | 111.11% |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | 6 | 0 | - |
| Dec 31, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cutera | 430 |
| Biomerica | 64 |
| Biora Therapeutics | 58 |
| Intelligent Bio Solutions | 50 |
| Aethlon Medical | 14 |
| NLS Pharmaceutics AG | 7 |
| Mangoceuticals | 3 |
| Hoth Therapeutics | 3 |
RNAZ News
- 16 days ago - TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance - GlobeNewsWire
- 2 months ago - TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate - GlobeNewsWire
- 2 months ago - TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate - GlobeNewsWire
- 4 months ago - TransCode Therapeutics, Inc. Announces Closing of Public Offering - GlobeNewsWire
- 4 months ago - TransCode Therapeutics, Inc. Announces Pricing of Public Offering - GlobeNewsWire
- 4 months ago - TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 5 months ago - Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements - GlobeNewsWire
- 6 months ago - TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138 - GlobeNewsWire